Does AVR normalize stroke-associated blood flow changes in the left atrium? Evidence suggests no—prothrombotic left atrial flow persists after AVR, even as the heart otherwise recovers. @MarcoSpartera@Barbara_Casadei@MarziaRigolli@RDMOxford@OxHealthBRC https://t.co/NmNQigzeMP
@dr_benoy_n_shah in these cases it’s better to truly normalise the flow rate (by DSE as the ‘normal normal’ flow rate is around 250 ); this tends to help clarifying - good idea to optimise HF meds but difficult to uptitrate sac/Val with low flow (likely severe) AS..I would go for DSE first
@dr_benoy_n_shah I would re-measure the LVOT diameter which may be overestimated and therefore overestimating the flow rate - would be good also the picture where the LVET is measured -
Today I hosted the NHS Recovery Forum in Downing Street with clinical leaders, health experts and ministers.
We are determined to ease pressure on the NHS, ensure better care for patients and deliver our promise to cut waiting lists ⤵️
Are you an interventional cardiologist interested in working at the Great Western Hospitals NHS Foundation Trust ? Opportunity to improve intravascular imaging skills and expertise. Apply here - WE ARE HIRING
https://t.co/KUTfpxzKyW
Subjects with obesity but without cardiovascular disease display left atrial myopathy which can be reverted with large weight loss targets @MarcoSpartera#AHAJournals https://t.co/T9vUKm3bbw
Do you know fellows/junior doctors interested in clinical research at the University of Oxford?
WE ARE HIRING @whyCMR@RDMOxford@UniofOxford
Apply here: https://t.co/Pe1966L53W
Many congrats @Z_Ashkir for publishing a nice review on the utility of 4D Flow CMR in the assessment of LV diastolic dysfunction. We look forward to contributing some original research in this space. @HEARTinMagnet@EylemLevelt @DrAJLewandowski
https://t.co/QASCiJ7zx2
Congratulations to my wife Anna-Lena Schaupp and coauthors for this nice publication on progressive multiple sclerosis. Great achievement!
@UniofOxford
https://t.co/aQLjeuQuRZ
@HEARTinMagnet @DrSeanCoffey @AnastasiaSMihai@LiamZhong Amazing congratulations! It would be interesting to see if 4D flow-derived parameters improve correlation with PCWP even more…
@FH_Verbrugge Interesting data, how did you rule out chronic respiratory issues ? Just asking as I might have missed it skimming through your tweet - very relevant study thank you!
RECOVERY trial result: in COVID patients with low oxygen and inflammation, tocilizumab saves lives, keeps you off a ventilator, and gets you out of hospital quicker.
Enormous thanks to the thousands of NHS staff and patients who made this possible.
Pre-print coming very soon.